- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (716)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (624)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (64)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (894)
- Research (390)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1772)
Daily aspirin and colon cancer risk
2 minute read | Published March 09, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 09, 2016
Could a daily aspirin help lower your chances of developing colon cancer? A new study suggests it might.
Researchers looked at the link between aspirin and cancer in more than 130,000 men and women over a 30-year span. They found that those who took a low-dose aspirin regularly over several years were about 3% less likely to develop cancer than those who didn’t.
When it came to colon cancer, researchers found a 19% lower risk.
This isn’t the first study to show that aspirin could curb cancer risk. But it may be the first to suggest aspirin’s benefit for those who get regular colon cancer screenings.
The study found that aspirin could have prevented nearly 9% of colon cancers in patients who were already getting routine colon screening. According to the findings, taking aspirin can complement the preventive benefit of colon cancer screenings.
We spoke with Ernest Hawk, M.D., Vice President of Cancer Prevention and Population Sciences, to learn more about aspirin and colon cancer risk. Here’s what he had to say.
How does aspirin lower colon cancer risk?
Aspirin reduces inflammation, which can affect cancer risk. It inhibits the development of prostaglandins, hormone-like compounds that cause cancer and help it spread.
Who should take aspirin regularly?
Those at significant risk for heart disease, heart attack or stroke should take daily low-dose aspirin.
The U.S. Preventive Services Task Force recommends daily low-dose aspirin for these conditions, and acknowledges the lower cancer risk benefits. If you’re interested in taking a daily low-dose aspirin, be sure to talk to your doctor before you start.
What’s considered a low dose of aspirin?
The study showed the benefit came from taking low doses of aspirin. Low doses of aspirin, or “baby aspirin,” are generally 81 milligrams in the United States (100 milligrams in Europe). A regular-strength adult aspirin is typically 325 milligrams.
What are the risks of taking a daily aspirin?
Risks include gastrointestinal bleeding and hemorrhagic stroke. Drinking alcohol can increase these risks. The risks of these side effects vary depending on a person’s health history.
What does this study mean for people with increased colon cancer risk? Should they start taking a daily aspirin?
No, we’re not recommending that patients with an increased colorectal cancer risk start taking a daily aspirin at this point. If you’re at increased risk, talk to your doctor to find healthy ways to lower your cancer risk.
Adults age 50 and older, and anyone at increased risk for colon cancer, should undergo regular screening. That’s the best way to mitigate cancer risk.
Research in this area is ongoing to see if aspirin may be used for cancer prevention in the future.
Can aspirin help lower risk for other types of cancer?
Probably. Early studies suggest that a daily low-dose aspirin may help lower risk for breast, prostate, esophageal, stomach and bladder.